95 devices · GMDN 55031
Mitochondrial antibody M2 (anti-Mi2) IVD kits use fluorescent immunoassay technology to detect specific antibodies in patient samples, helping diagnose autoimmune conditions like dermatomyositis or systemic sclerosis. Clinically, these tests aid in identifying inflammatory myopathies or connective tissue disorders by targeting the Mi2 protein within mitochondria.
These kits are typically in-vitro diagnostics (IVDs) regulated under medical device frameworks, often requiring compliance with standards for assay performance, accuracy, and safety. They are commonly supplied as complete reagent sets for laboratory use, with classification varying by jurisdiction based on risk factors like patient impact and intended use.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.